Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01623440 · ClinicalTrials.gov registry record

Food Reward in Native American Women

A clinical trial of Obesity, sponsored by University of Minnesota.

Completed
Registry status
69
Enrollment target
1
Study location

NCT01623440: Completed study of Obesity, sponsored by University of Minnesota.

NCT01623440 is a study of Obesity that has completed, run by University of Minnesota. The registered enrollment target is 69 participants, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01623440, a study of Obesity, has completed, sponsored by University of Minnesota.

COMPLETED
Registry status
69 participants
Enrollment target
1
Study location

Study Summary

This study aims to characterize the neurobiology of obesity in American Indians (AI) using functional MRIs to examine the correlation between brain response to food stimuli in AI women. A functional MRI (fMRI) is used to visualize brain activity when obese and lean AI women look at images of fattening food, non-fattening food and non-food objects. Additionally examined is the effect of the drug naltrexone to suppress brain response to visual food cues and calorie intake in the women.

Primary Outcome

fMRI activation in the brain in response to visual food cue

Conditions Studied

Interventions

  • COMBINATION_PRODUCT Placebo and fMRI
  • COMBINATION_PRODUCT Naltrexone and fMRI

Study Locations (1)

Minnesota

  • University of Minnesota - Minneapolis

Trial Details

FieldValue
Enrollment Target 69 participants
Start Date 2009-11
Est. Completion 2015-07
University of Minnesota

966 total trials

What the finished NCT01623440 record still lists

NCT01623440 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 69 participants, a relatively small participant target, below the 819-participant average among 1,053 other Obesity trials with a reported enrollment target (92% lower).

The record links to 1 condition, with Obesity appearing as the primary indexed condition, and to 2 interventions - of which Placebo and fMRI is the first listed.

NCT01623440 reports a single indexed study location in Minnesota.

Frequently Asked Questions

What is clinical trial NCT01623440 about?

NCT01623440 is a clinical study titled "Food Reward in Native American Women". This study aims to characterize the neurobiology of obesity in American Indians (AI) using functional MRIs to examine the correlation between brain response to food stimuli in AI women. A functional MRI (fMRI) is used to visualize brain activity when obese and lean AI women look at images of fatteni...

What is the current status of trial NCT01623440?

This trial is currently completed. The enrollment target is 69 participants. The study started on 2009-11. Estimated completion is 2015-07.

What conditions does trial NCT01623440 study?

This clinical trial studies the following conditions: Obesity.

What interventions are being tested in trial NCT01623440?

The interventions under investigation include: Placebo and fMRI (COMBINATION_PRODUCT), Naltrexone and fMRI (COMBINATION_PRODUCT).

Who is sponsoring clinical trial NCT01623440?

This trial is sponsored by University of Minnesota, which has 966 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT01623440 being conducted?

This trial has 1 study location across Minnesota. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obesity

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT01623440's enrollment target sits among peer trials

69 606th of 1053 higher than 444 of 1,053 other Obesity trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Obesity trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04020575 · 69 participants · Phase 1

    Autologous huMNC2-CAR44 or huMNC2-CAR22 T Cells for Breast Cancer Targeting Cleaved Form of MUC1 (MUC1*)

  • NCT04163614 · 69 participants · NA

    Blood Pressure Slopes and Ultrafiltration in Hemodialysis Patients

  • NCT04164641 · 69 participants · NA

    Noraxon myoRESEARCH™ Software Gait Analysis Evaluation and Orthotic Gait Correction in Reducing Diabetic Foot Ulceration Or Subsequent Amputation in Patients With a History of a Diabetic Foot Ulceration

  • NCT04493372 · 69 participants · NA

    Deciphering Preserved Autonomic Function After Spinal Cord Injury

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01623440, the US trial registry maintained by the National Library of Medicine. NCT01623440 (small enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.